Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Natalie N Kinloch^#^{1

2}, Yanqin Ren^#³, Winiffer D Conce Alberto³, Winnie Dong², Pragya Khadka³, Szu Han Huang³, Talia M Mota³, Andrew Wilson⁴, Aniqa Shahid^{1

2}, Don Kirkby², Marianne Harris^{2

5}, Colin Kovacs⁶, Erika Benko⁶, Mario A Ostrowski⁷, Perla M Del Rio Estrada⁸, Avery Wimpelberg⁹, Christopher Cannon⁹, W David Hardy⁹, Lynsay MacLaren⁹, Harris Goldstein¹⁰, Chanson J Brumme^{2

5}, Guinevere Q Lee³, Rebecca M Lynch⁴, Zabrina L Brumme^{11

12}, R Brad Jones^{13

14}

Affiliations

¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
² British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
³ Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
⁴ Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA.
⁵ Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
⁶ Maple Leaf Medical Clinic, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Center for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
⁹ Whitman Walker Health, Washington, DC, USA.
¹⁰ Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
¹¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada. zbrumme@sfu.ca.
¹² British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. zbrumme@sfu.ca.
¹³ Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. rbjones@med.cornell.edu.
¹⁴ Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA. rbjones@med.cornell.edu.

^# Contributed equally.

Published Erratum

Natalie N Kinloch et al. Nat Commun. 2021.

. 2021 May 13;12(1):2958.

doi: 10.1038/s41467-021-23515-z.

¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
² British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
³ Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
⁴ Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA.
⁵ Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
⁶ Maple Leaf Medical Clinic, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Center for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
⁹ Whitman Walker Health, Washington, DC, USA.
¹⁰ Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
¹¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada. zbrumme@sfu.ca.
¹² British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. zbrumme@sfu.ca.
¹³ Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. rbjones@med.cornell.edu.
¹⁴ Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA. rbjones@med.cornell.edu.

^# Contributed equally.

No abstract available

Erratum for

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA).
Kinloch NN, Ren Y, Conce Alberto WD, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, Wimpelberg A, Cannon C, Hardy WD, MacLaren L, Goldstein H, Brumme CJ, Lee GQ, Lynch RM, Brumme ZL, Jones RB. Kinloch NN, et al. Nat Commun. 2021 Jan 8;12(1):165. doi: 10.1038/s41467-020-20442-3. Nat Commun. 2021. PMID: 33420062 Free PMC article.